← Back to patent-cliff list
CAS 79099-07-3
tert-butyl 4-oxopiperidine-1-carboxylatetert-Butyl 4-oxopiperidine-1-carboxylate
Codes: EDOX-020, Conteltinib-007, Vazegepant-001, Dalpiciclib Isethionate-022, (XV)965082-1-b
Application context (from source-drug indications)
Pulmonary embolismEdoxaban Tosilate HydrateVenous thromboembolismEdoxaban Tosilate HydrateStrokeEdoxaban Tosilate HydrateEmbolismEdoxaban Tosilate HydrateVenous thrombosisEdoxaban Tosilate HydrateIschaemic strokeEdoxaban Tosilate HydrateNon-small cell lung cancerConteltinibSolid tumourConteltinibPancreatic cancerConteltinibMigraineZavegepantMigraine without auraZavegepant有先兆的偏头痛ZavegepantCluster headacheZavegepantAsthmaZavegepantCOVID-19ZavegepantBreast cancerDalpiciclib IsethionateMetastatic breast cancerDalpiciclib IsethionateProstate cancerDalpiciclib Isethionate三阴性乳腺癌Dalpiciclib IsethionateMeningiomaDalpiciclib IsethionateHepatic function declineDalpiciclib IsethionateMarginal zone B-cell lymphomaOrelabrutinibMantle cell lymphomaOrelabrutinibChronic lymphocytic leukaemiaOrelabrutinibImmune thrombocytopenic purpuraOrelabrutinibSystemic lupus erythematosusOrelabrutinibMultiple sclerosisOrelabrutinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Edoxaban Tosilate Hydrate | Tier B — Position early | 2028 |
| Dextran/Calcium Chloride/Potassium Chloride/Sodium Chloride/Sodium lactate | Tier C — Watch / trade | - |
| Conteltinib | Tier C — Watch / trade | - |
| Zavegepant | Tier C — Watch / trade | - |
| Dalpiciclib Isethionate | Tier C — Watch / trade | - |
| Orelabrutinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
lithium 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylate→tert-butyl 4-oxopiperidine-1-carboxylate→tert-butyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate→tert-butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate→2-bromo-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine→2-bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
Dextran/Calcium Chloride/Potassium Chloride/Sodium Chloride/Sodium lactateOriginator routesteps: 11total yield: 685 g
6-aminopyrimidine-2,4(1H,3H)-dione→2-chloroacetaldehyde→7H-pyrrolo[2,3-d]pyrimidine-2,4-diol→6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine-2,4-diol→2,4-dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine→2,4-dichloro-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine→tert-butyl 4-oxopiperidine-1-carboxylate→1-methylpiperazine→tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate→1-methyl-4-(piperidin-4-yl)piperazine→4-fluoro-2-methoxy-1-nitrobenzene→1-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine→2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline→2-methoxyethan-1-ol→4-chloro-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-2-amine→2-amino-N-isopropylbenzenesulfonamide→N-isopropyl-2-((2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzenesulfonamide
6-aminopyrimidine-2,4(1H,3H)-dione→2-chloroacetaldehyde→7H-pyrrolo[2,3-d]pyrimidine-2,4-diol→6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine-2,4-diol→2,4-dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine→2,4-dichloro-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine→tert-butyl 4-oxopiperidine-1-carboxylate→1-methylpiperazine→tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate→1-methyl-4-(piperidin-4-yl)piperazine→4-fluoro-2-methoxy-1-nitrobenzene→1-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine→2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline→2-methoxyethan-1-ol→4-chloro-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-2-amine→2-amino-N-isopropylbenzenesulfonamide→N-isopropyl-2-((2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-7-(4-methoxybenzyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)benzenesulfonamide
tert-butyl 4-oxopiperidine-1-carboxylate→methyl 2-(dimethoxyphosphoryl)acetate→tert-butyl 4-(2-methoxy-2-oxoethylidene)piperidine-1-carboxylate→tert-butyl 4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate→2-nitrobenzaldehyde→tert-butyl 4-(1-hydroxy-3-methoxy-1-(2-nitrophenyl)-3-oxopropan-2-yl)piperidine-1-carboxylate→tert-butyl 4-(4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)piperidine-1-carboxylate→3-(piperidin-4-yl)quinolin-2(1H)-one hydrochloride→2,6-dimethylaniline→4-iodo-2,6-dimethylaniline hydrochloride→methyl ((benzyloxy)carbonyl)-L-serinate→methyl 2-(((benzyloxy)carbonyl)amino)acrylate→methyl (Z)-3-(4-amino-3,5-dimethylphenyl)-2-(((benzyloxy)carbonyl)amino)acrylate→methyl (R)-3-(4-amino-3,5-dimethylphenyl)-2-(((benzyloxy)carbonyl)amino)propanoate→methyl (R)-2-(((benzyloxy)carbonyl)amino)-3-(7-methyl-1H-indazol-5-yl)propanoate→methyl (R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate→methyl (R)-3-(7-methyl-1H-indazol-5-yl)-2-(4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamido)propanoate→(R)-3-(7-methyl-1H-indazol-5-yl)-2-(4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamido)propanoic acid→1-(1-methylpiperidin-4-yl)piperazine
tert-Butyl 4-(6-aminopyridin-3-yl)piperidine-1-carboxylate→(9H-Fluoren-9-yl)methyl (5-bromopyridin-2-yl)carbamate→tert-Butyl 4-oxopiperidine-1-carboxylate→tert-Butyl 4-[6-([[(9H-fluoren-9-yl)methoxy]carbonyl]amino)pyridin-3-yl]-4-hydroxypiperidine-1-carboxylate
tert-Butyl 4-[5-carbamoyl-6-(4-phenoxyphenyl)pyridin-2-yl]piperidine-1-carboxylate→3-Nitropropanal→3-Oxo-3-(4-phenoxyphenyl)propanamide→(2Z)-5-Nitro-2-(4-phenoxybenzoyl)pent-2-enamide→tert-Butyl 4-oxopiperidine-1-carboxylate→tert-Butyl 4-[(3Z)-4-carbamoyl-1-nitro-5-oxo-5-(4-phenoxyphenyl)pent-3-en-1-yl]-4-hydroxypiperidine-1-carboxylate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | (R)-METHYL 2-(((BENZYLOXY)CARBONYL)AMINO)-3-(7-METHYL-1H-INDAZOL-5-YL)PROPANOATE Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 3-(piperidin-4-yl)quinolin-2(1h)-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 1-(1-Methyl-4-piperidinyl)piperazine Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl)propanoate dihydrochloride Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 1H-Indazole-5-propanoic acid,α-amino-7-methyl-,methyl ester, (αR)- Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 1-(1-METHYLPIPERIDIN-4-YL)PIPERAZINE 3HCL Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.